Research Progress of HGF/MET Signaling Pathway in EGFR-TKI Resistance 
in Non-small Cell Lung Cancer

Research Progress of HGF/MET Signaling Pathway in EGFR-TKI Resistance 
in Non-small Cell Lung Cancer

Lung cancer is one of the most common malignant tumors of the world, and non-small cell lung cancer (NSCLC) makes up about 80%. The hepatocyte growth factor (HGF)/mesenchymal-epithelial transition factor (MET) signal pathway has pleiotropic effects on many biological processes. However, aberrant HGF...

Full description

Bibliographic Details
Main Authors: Shilong SONG, Minghong BI
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
HGF
MET
Lung neoplasms
EGFR-TKI
Resistance
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2014.10.08

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2014.10.08

Similar Items